All In Biotech

Drug Trial Radar · NCT04800237

Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of VQW-765 in Patients With Performance Anxiety

Last checked: Nov 20, 2026Latest source record: Mar 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 230 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

230

Actual

Start

Feb 23, 2021

Primary completion

Aug 2, 2022

Study completion Aug 2, 2022

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 16, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in male and female participants with performance anxiety.

Conditions

  • Performance Anxiety

Interventions

  • VQW-765Drug

    oral capsule

  • PlaceboDrug

    oral capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subjective Units of Distress Scale (SUDS)Time frame: 1 Day

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Vanda Investigational Site

    Tempe, Arizona

  • Vanda Investigational Site

    Beverly Hills, California

  • Vanda Investigational Site

    Garden Grove, California

  • Vanda Investigational Site

    San Jose, California

  • Vanda Investigational Site

    Torrance, California

  • Vanda Investigational Site

    Orlando, Florida

  • Vanda Investigational Site

    Boston, Massachusetts

  • Vanda Investigational Site

    North Dartmouth, Massachusetts

  • Vanda Investigational Site

    Las Vegas, Nevada

  • Vanda Investigational Site

    Berlin, New Jersey

  • Vanda Investigational Site

    New York, New York

  • Vanda Investigational Site

    Staten Island, New York

  • Vanda Investigational Site

    Raleigh, North Carolina

  • Vanda Investigational Site

    Cincinnati, Ohio

  • Vanda Investigational Site

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.